Dr. Mitchell S. Elkind — (212) 305-1710

Stroke risk factors and prevention. Focus on different inflammatory markers and infections, such as C. pneumoniae and periodontal disease, as potential causes of atherosclerosis and ischemic stroke. Use of high-resolution duplex doppler ultrasonography as a measure of stroke risk. Clinical trials of neuroprotectants and surgical hemicraniectomy for acute stroke, and antiplatelet and other therapies for stroke prevention.

Dr. Randolph S. Marshall — (212) 305-8389

Behavioral and physiologic investigation of early hemispheric ischemia in patients undergoing therapeutic carotid balloon test occlusions. Evaluation of visual-spatial dysfunction using behavioral and functional imaging methodologies.

Dr. Jay P. Mohr — (212) 305-8033

Research is focused on clinical, radiologic and pathologic correlations of clinical stroke syndromes; doppler studies and cerebral hemodynamics of large-artery disease; arteriovenous malformations (AVMs); studies of the course and outcome of stroke and its various subtypes; cardiac and hematologic risk factors of stroke; and modification of stroke outcome by specific therapies tested in multi-center trials.

Dr. Ralph L. Sacco — (212) 305 1710

Research focuses on stroke prevention and risk factor detection, design and conduct of clinical tnials, and neurological outcomes following stroke. The Northern Manhattan Stroke Study (NOMASS) is an NIH funded cohort study of stroke in the community. Dr. Sacco is also co director of the Neuroepidemiology Training Program.

Dr. Clinton Wright — (212) 305-1710

Study of the effect of different forms of vascular disease on cognitive impairment and decline in a population-based study.